<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="The most compliant trial I ever saw had 500 protocol deviations. What if moving faster IS how we ensure compliance - when we move smart?">
    <title>When Speed Is the Path to Compliance - Velocity Foundry</title>
    <link rel="stylesheet" href="../assets/css/style.css">
    <link rel="stylesheet" href="../assets/css/animations.css">
    <link rel="stylesheet" href="../assets/css/blog.css">
</head>
<body>
    <!-- Navigation -->
    <nav class="nav">
        <div class="container">
            <a href="../index.html" class="nav-logo">Velocity Foundry</a>
            <ul class="nav-menu">
                <li><a href="../assess.html">Assess</a></li>
                <li><a href="../tools.html">Tools</a></li>
                <li><a href="../book.html">Book</a></li>
                <li><a href="../blog.html">Blog</a></li>
            </ul>
        </div>
    </nav>

    <!-- Post Content -->
    <article class="container" style="padding: var(--space-xl) var(--space-md);">
        <nav class="post-nav" style="border-bottom: 2px solid var(--gray-200); padding-bottom: var(--space-sm); margin-bottom: var(--space-lg);">
            <a href="../blog.html">← All Posts</a>
        </nav>

        <header class="post-header">
            <time>September 9, 2024</time>
            <h1>When Speed Is the Path to Compliance</h1>
            <p class="post-byline">By Johan Strömquist</p>
        </header>

        <div class="post-content">
            <p>The most compliant trial I ever saw had 500 protocol deviations. It also took 12 years.</p>

            <p>Every biotech compliance team knows the drill. Move carefully. Document everything. Check it twice. Then check it again. Because when something goes wrong - and something always goes wrong - you need to show you were careful.</p>

            <p>Except here's what actually happens when you're that careful:</p>

            <p>Your protocol takes six months to finalize. By month seven, the science has moved on. Amendment one. A key site interprets eligibility differently. Amendment two. Enrollment lags, you need more sites. Amendment three. Each change takes months, generates new training requirements, creates fresh opportunities for deviation.</p>

            <p>The careful trial doesn't have fewer problems. It has different problems. Older problems. Compounded problems.</p>

            <p>Meanwhile, the entire regulatory framework has been quietly rewritten for a different game entirely.</p>

            <h2>The Plot Twist Hidden in Plain Sight</h2>

            <p>Read the recent guidances - really read them - and you'll notice something interesting. The regulators aren't asking for more caution. These guidances are built for change.</p>

            <p>ICH E6(R3) rebuilds the entire framework around "proportionate" and "fit-for-purpose" approaches. Translation: Stop overengineering. Build what you need. Move at the speed your trial demands.</p>

            <p>M11 makes protocols machine-readable and modular. When your protocol is structured data, amendments become updates, not rewrites. Change an inclusion criterion at 9am. Every site is screening with it by lunch. That's not fiction - that's M11 working as designed.</p>

            <p>The FDA's decentralized trial guidance doesn't grudgingly permit remote activities. It enthusiastically enables them. Run trials from anywhere. Recruit from everywhere. Start next week, not next quarter.</p>

            <p>The AI guidances from FDA and EMA acknowledge risks while laying out frameworks for machines to handle the rote compliance work that humans do slowly and badly.</p>

            <p>Every major guidance in the last two years points the same direction: The agencies know that slow trials accumulate risk. They're building frameworks for you to move at the natural speed of your science.</p>

            <h2>The Compliance Debt You Don't See</h2>

            <p>Think about what really happens in Year 5 of a "careful" trial:</p>

            <p>Half your original sites are running on muscle memory. The protocol they're following exists mostly in their heads, supplemented by a stack of amendments they may or may not have fully internalized.</p>

            <p>Your data management team has turned over twice. The new team is cleaning data based on their interpretation of decisions made by people who left years ago. Every query becomes an archaeological expedition. And institutional knowledge has a best-before date. Wait two years, and you're not getting facts, you're getting guesses.</p>

            <p>Your trial is compliant with 2020's best practices, reviewed under 2025's standards. That gap isn't precision - it's debt.</p>

            <p>Now picture the alternative: A trial that moves fast enough to avoid these problems. Sites stay engaged. Data gets cleaned while it's fresh. Amendments are minor course corrections, not major overhauls.</p>

            <p>Which trial would you rather defend in an inspection?</p>

            <h2>The Velocity Paradox</h2>

            <p>Yes, your oncology survival endpoint still takes five years. But does patient recruitment? Does database lock? Does your CSR?</p>

            <p>When you optimize for appropriate speed:</p>

            <p><strong>Protocol drift reduces dramatically</strong> when trials maintain momentum. A focused two-year trial beats a meandering five-year one - even if they're studying the same indication.</p>

            <p><strong>Data quality improves</strong> when it's reviewed in real-time. Query rates drop because questions get answered while the people with answers are still around.</p>

            <p><strong>Amendments become surgical.</strong> Update specific data fields instead of rewriting entire sections. Necessary changes don't cascade into unnecessary delays.</p>

            <p><strong>Technology stays current</strong> because you're implementing today's tools for trials ending in the foreseeable future, not legacy systems for trials that might end someday.</p>

            <p>Speed isn't about rushing. It's about removing unnecessary friction - all those accumulated processes that add time without adding value.</p>

            <h2>The Infrastructure Inversion</h2>

            <p>The agencies figured out what most sponsors haven't: Compliance infrastructure should enable speed, not prevent it.</p>

            <p>When protocols are structured data, every system can read them. No manual configuration, no interpretation errors, no delays. Update a dosing schedule in the protocol, watch it flow through every system automatically.</p>

            <p>When quality is built into design, you don't need layers of review. Real-time edit checks beat retrospective monitoring every time.</p>

            <p>When AI handles repetitive compliance tasks - checking ranges, flagging deviations, generating reports - humans focus on what matters: the science, the strategy, the insights that require judgment.</p>

            <p>This isn't about being less compliant. It's about being so systematically compliant that speed happens naturally.</p>

            <h2>The Scale Reality</h2>

            <p>Most biotechs can't build this alone.</p>

            <p>You're running two trials, maybe three. You can't justify building sophisticated velocity infrastructure any more than you'd build your own manufacturing plant. The math doesn't math.</p>

            <p>Big pharma has the scale to build their own. Small biotechs face a choice: access existing infrastructure through partners who've already built it, or keep playing defense with Excel sheets and email chains.</p>

            <p>The playbook already exists. Companies are running trials on it right now. We built it at SSI, others have built their versions. The point is: you don't have to start from scratch. The mistakes have been made, the approaches refined, the templates battle-tested.</p>

            <h2>The Choice That Changes Everything</h2>

            <p>What if we've been asking the wrong question all along?</p>

            <p>Instead of "How can we ensure compliance while moving faster?" try: "What if moving faster IS how we ensure compliance - when we move smart?"</p>

            <p>The regulators aren't lowering standards. They're recognizing what modern technology makes possible: that appropriate speed and quality are partners, not opposites. The riskiest thing you can do is let a trial drag on unnecessarily, accumulating problems like compound interest.</p>

            <p>They've built the frameworks. Published the guidances. Shown you the door.</p>

            <p>Compliance isn't about checking boxes anymore. It's about building systems so elegant, so automated, so intelligent that quality happens by default. And speed? Speed is what happens when nothing unnecessary is slowing you down.</p>

            <p>So here's the real question: What's actually slowing you down - the regulations, or your interpretation of them?</p>

            <p>The future of compliance is velocity - appropriate, intelligent, enabled by design. Ready to access the infrastructure that makes it possible? Let's talk. - SSI Strategy</p>
        </div>

        <nav class="post-nav">
            <a href="../blog.html">← Back to all posts</a>
        </nav>
    </article>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-section">
                    <h4>About</h4>
                    <p>By Johan Strömquist, President & Chief Innovation Officer at SSI Strategy / NDA Group</p>
                </div>
                <div class="footer-section">
                    <h4>Contact</h4>
                    <p>Email: <a href="mailto:johan.stromquist@ssistrategy.com">johan.stromquist@ssistrategy.com</a></p>
                    <p>LinkedIn: <a href="https://linkedin.com/in/johanstromquist" target="_blank">@johanstromquist</a></p>
                </div>
                <div class="footer-section">
                    <h4>Resources</h4>
                    <ul>
                        <li><a href="../assess.html">Velocity Assessment</a></li>
                        <li><a href="../tools.html">Templates & Tools</a></li>
                        <li><a href="../book.html">The Book</a></li>
                        <li><a href="../blog.html">Blog</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2025 Johan Strömquist. All rights reserved.</p>
                <p class="footer-motto">Transform faster. Deliver sooner. Live better.</p>
            </div>
        </div>
    </footer>
</body>
</html>